/Cencora%20Inc_%20logo%20on%20phone-by%20Robert%20Way%20via%20Shutterstock.jpg)
- Cencora (COR) is a healthcare solutions provider with strong technical “buy” signals and consistent price appreciation.
- The stock has gained 20.47% since a “buy” signal was issued on Jan. 16.
- Drug stocks like Cencora tend to be recession-proof, making today’s Chart of the Day especially relevant following a tariffs-driven selloff.